Qatar vs Togo: Cause of death, by non-communicable diseases, ages 15-59, male
Qatar
46.7%
in 2021
Togo
46.9%
in 2021
Qatar rank
108th
Togo rank
106th
Cause of death, by non-communicable diseases, ages 15-59, male over time
- Qatar
- Togo
How they compare
Togo currently reports 46.9% against 46.7% in Qatar, a difference of 0.2%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Qatar ahead.
Qatar ranks 108th and Togo ranks 106th of 185 countries.
Qatar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Qatar | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 60.6% | 37.3% | 23.3% | Qatar |
| 2010s | 57.3% | 44.7% | 12.5% | Qatar |
| 2020s | 50.8% | 47.9% | 2.9% | Qatar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, male, Qatar or Togo?
- Togo, at 46.9% against 46.7% in Qatar as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59, male between Qatar and Togo?
- 0.2%, with Togo ahead.
- How many years of comparable data are there for Qatar and Togo?
- 6 years are reported by both, from 2000 to 2021.
- How do Qatar and Togo rank globally for cause of death, by non-communicable diseases, ages 15-59, male?
- Qatar ranks 108th and Togo ranks 106th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59, male (% of total male deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 15-59 due to non-communicable diseases divided by number of all male deaths ages 15-59, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.